Four updates:
1. Surveillance: Nationwide, the percentage of laboratory specimens testing positive for COVID-19 decreased slightly. Four of 10 HHS surveillance regions saw an increase in the percentage of positive specimens: the Midwest, Central, Mountain and New York/New Jersey/Puerto Rico. Three other regions — the Southeast, South Central and West — have seen a higher percentage of positive COVID-19 tests than in March, but are now showing evidence of a decline.
2. Mortality: About 9.1 percent of deaths nationwide were attributed to flu, pneumonia or COVID-19 in the week ending July 18, marking the first increase in deaths after 12 weeks of decline.
3. Hospitalizations: The cumulative hospitalization rate for all age groups was 120.9 hospitalizations per 100,000 population. Hospitalizations increased for three straight weeks between June 20 and July 11.
4. Outpatient activity: Emergency department and outpatient visits for symptoms related to COVID-19 remained below baseline nationwide. The percentage of ED visits for COVID-19-like symptoms also decreased in the Southeast, West and South Central regions, which previously reported the highest activity.
More articles on public health:
6 potential long-term side effects of COVID-19
NYT: COVID-19 hospitalization rates in 20 metropolitan areas
Underlying conditions put nearly half of adults in CDC study at risk for COVID-19
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
